Dr Sulaiman Al-Habib Medical Services Group Co
SAU:4013
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
261
335.4341
|
| Price Target |
|
We'll email you a reminder when the closing price reaches SAR.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Dr Sulaiman Al-Habib Medical Services Group Co
Dr Sulaiman Al-Habib Medical Services Group Co
Revenue
Dr Sulaiman Al-Habib Medical Services Group Co
Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Dr Sulaiman Al-Habib Medical Services Group Co
SAU:4013
|
Revenue
ď·Ľ9.5B
|
CAGR 3-Years
17%
|
CAGR 5-Years
16%
|
CAGR 10-Years
N/A
|
|
|
Dallah Healthcare Company SJSC
SAU:4004
|
Revenue
ď·Ľ3.1B
|
CAGR 3-Years
21%
|
CAGR 5-Years
21%
|
CAGR 10-Years
14%
|
|
|
National Medical Care Company JSC
SAU:4005
|
Revenue
ď·Ľ1.2B
|
CAGR 3-Years
11%
|
CAGR 5-Years
11%
|
CAGR 10-Years
6%
|
|
|
Mouwasat Medical Services Company SJSC
SAU:4002
|
Revenue
ď·Ľ2.8B
|
CAGR 3-Years
10%
|
CAGR 5-Years
10%
|
CAGR 10-Years
12%
|
|
|
A
|
Al Hammadi Holding Co
SAU:4007
|
Revenue
ď·Ľ1.1B
|
CAGR 3-Years
9%
|
CAGR 5-Years
3%
|
CAGR 10-Years
9%
|
|
|
D
|
Dr Soliman Abdel Kader Fakeeh Hospital Company SCJSC
SAU:4017
|
Revenue
ď·Ľ2.3B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Dr Sulaiman Al-Habib Medical Services Group Co
Glance View
Dr. Sulaiman Al-Habib Medical Services Group Co. (HMG) has emerged as a beacon of healthcare excellence in the Middle East, rooted deeply in a commitment to enhancing patient care. Founded in 1995 by Dr. Sulaiman Al-Habib, the company has grown from a singular hospital in Riyadh to a sprawling network of advanced medical facilities across Saudi Arabia and the region. With a mission to deliver high-quality medical services, HMG operates multiple hospitals, clinics, and specialized centers, ensuring that a diverse array of healthcare needs—from routine check-ups to complex surgeries—are met with state-of-the-art technology and skilled practitioners. The company’s dedication to continuous improvement is evident in its robust investment in research and development, alongside strategic partnerships that enhance its medical offerings. For investors, HMG represents a compelling opportunity within the booming healthcare sector. As the demand for quality medical services rises—fueled by a growing population and a heightened focus on health—HMG's established reputation and expansive market presence position it favorably for continued growth. The group's financial stability, underpinned by innovative healthcare solutions and a strong brand, highlights its potential for profitability in the years to come. With a vision to lead in integrated healthcare services, Dr. Sulaiman Al-Habib Medical Services Group Co. not only stands out for its operational excellence but also offers investors the chance to be part of a transformative journey in the healthcare landscape of the Middle East.
See Also
What is Dr Sulaiman Al-Habib Medical Services Group Co's Revenue?
Revenue
9.5B
SAR
Based on the financial report for Dec 31, 2023, Dr Sulaiman Al-Habib Medical Services Group Co's Revenue amounts to 9.5B SAR.
What is Dr Sulaiman Al-Habib Medical Services Group Co's Revenue growth rate?
Revenue CAGR 5Y
16%
Over the last year, the Revenue growth was 14%. The average annual Revenue growth rates for Dr Sulaiman Al-Habib Medical Services Group Co have been 17% over the past three years , 16% over the past five years .
You don't have any saved screeners yet
